{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:38:27Z","timestamp":1790707107130,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["SFI20101201530"],"award-info":[{"award-number":["SFI20101201530"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["R19040CC"],"award-info":[{"award-number":["R19040CC"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Epigenetics & Cancer Program"},{"name":"the Association : \u00ab Le Cancer du sein, parlons-en \u00bb"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2021,2,11]]},"DOI":"10.1038\/s41388-020-01589-1","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T08:45:11Z","timestamp":1609836311000},"page":"1118-1127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Men1 disruption in Nkx3.1-deficient mice results in ARlow\/CD44+ microinvasive carcinoma development with the dysregulated AR pathway"],"prefix":"10.1038","volume":"40","author":[{"given":"Romain","family":"Teinturier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Decaussin-Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Vlaeminck-Guillem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Vacherot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Firlej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-4282","authenticated-orcid":false,"given":"R\u00e9my","family":"Bonnavion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Abou Ziki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Le Romancer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-8951","authenticated-orcid":false,"given":"Chang Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"1589_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"R Siegel","year":"2015","unstructured":"Siegel R, Miller K, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"1589_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","volume":"32","author":"EG Bluemn","year":"2017","unstructured":"Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, et al. Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell. 2017;32:474\u201389.","journal-title":"Cancer Cell"},{"key":"1589_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06067-7","volume":"9","author":"Q Li","year":"2018","unstructured":"Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, et al. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun. 2018;9:3600.","journal-title":"Nat Commun"},{"key":"1589_CR4","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, et al. Genomic correlates of clinical outcome in advanced prostate cancer. PNAS. 2019;116:11428\u201336.","journal-title":"PNAS."},{"key":"1589_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487:239\u201343.","journal-title":"Nature."},{"key":"1589_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","volume":"81","author":"A Shilatifard","year":"2012","unstructured":"Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem. 2012;81:65\u201395.","journal-title":"Annu Rev Biochem"},{"key":"1589_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.cell.2015.06.053","volume":"162","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;162:454.","journal-title":"Cell"},{"key":"1589_CR8","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","volume":"24","author":"A Yokoyama","year":"2004","unstructured":"Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol. 2004;24:5639\u201349.","journal-title":"Mol Cell Biol"},{"key":"1589_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/bies.201200007","volume":"34","author":"AT Thiel","year":"2012","unstructured":"Thiel AT, Huang J, Lei M, Hua X. Menin as a hub controlling mixed lineage leukemia. Bioessays. 2012;34:771\u201380.","journal-title":"Bioessays."},{"key":"1589_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMc1406028","volume":"371","author":"KM Dreijerink","year":"2014","unstructured":"Dreijerink KM, Goudet P, Burgess JR, Valk GD, International Breast Cancer in MEN1 Study Group. Breast-cancer predisposition in multiple endocrine neoplasia type 1. N Engl J Med. 2014;371:583\u20134.","journal-title":"N Engl J Med"},{"key":"1589_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/path.4146","volume":"229","author":"C Seigne","year":"2013","unstructured":"Seigne C, Auret M, Treilleux I, Bonnavion R, Assade F, Carreira C, et al. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands. J Pathol. 2013;229:546\u201358.","journal-title":"J Pathol"},{"key":"1589_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nm.3830","volume":"21","author":"R Malik","year":"2015","unstructured":"Malik R, Khan AP, Asangani IA, Cie\u015blik M, Prensner JR, Wang X, et al. Targeting the MLL complex in castration-resistant prostate cancer. Nat Med. 2015;21:344\u201352.","journal-title":"Nat Med"},{"key":"1589_CR13","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.celrep.2017.02.025","volume":"18","author":"KMA Dreijerink","year":"2017","unstructured":"Dreijerink KMA, Groner AC, Vos ESM, Font-Tello A, Gu L, Chi D, et al. Enhancer-mediated oncogenic function of the menin tumor suppressor in breast cancer. Cell Rep. 2017;18:2359\u201372.","journal-title":"Cell Rep"},{"key":"1589_CR14","first-page":"4836","volume":"63","author":"P Bertolino","year":"2003","unstructured":"Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX, Wang ZQ. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res. 2003;63:4836\u201341.","journal-title":"Cancer Res"},{"key":"1589_CR15","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1158\/0008-5472.CAN-12-0283","volume":"72","author":"N Floc\u2019h","year":"2012","unstructured":"Floc\u2019h N, Kinkade CW, Kobayashi T, Aytes A, Lefebvre C, Mitrofanova A, et al. Dual targeting of the Akt\/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model. Cancer Res. 2012;72:4483\u201393.","journal-title":"Cancer Res"},{"key":"1589_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature08361","volume":"461","author":"X Wang","year":"2009","unstructured":"Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 2009;461:495\u2013500.","journal-title":"Nature."},{"key":"1589_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.stem.2012.03.009","volume":"10","author":"J Qin","year":"2012","unstructured":"Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, et al. The PSA(-\/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell. 2012;10:556\u201369.","journal-title":"Cell Stem Cell"},{"key":"1589_CR18","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.18632\/oncotarget.2953","volume":"6","author":"AP Rybak","year":"2015","unstructured":"Rybak AP, Bristow RG, Kapoor A. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget. 2015;6:1900\u201319.","journal-title":"Oncotarget."},{"key":"1589_CR19","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1002\/jcb.27573","volume":"120","author":"D Srinivasan","year":"2019","unstructured":"Srinivasan D, Senbanjo L, Majumdar S, Franklin RB, Chellaiah MA. Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2. J Cell Biochem. 2019;120:2413\u201328.","journal-title":"J Cell Biochem"},{"key":"1589_CR20","doi-asserted-by":"publisher","first-page":"23959","DOI":"10.18632\/oncotarget.4260","volume":"6","author":"X Liu","year":"2015","unstructured":"Liu X, Chen X, Rycaj K, Chao HP, Deng Q, Jeter C, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959\u201386.","journal-title":"Oncotarget."},{"key":"1589_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22:298\u2013305.","journal-title":"Nat Med"},{"key":"1589_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15:701\u201311.","journal-title":"Nat Rev Cancer"},{"key":"1589_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/pcan.2008.45","volume":"12","author":"PL Paris","year":"2009","unstructured":"Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, et al. An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer. Prostate Cancer Prostatic Dis. 2009;12:184\u201391.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1589_CR24","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","volume":"25","author":"L Patrawala","year":"2006","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006;25:1696\u2013708.","journal-title":"Oncogene."},{"key":"1589_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mce.2010.10.007","volume":"332","author":"DM Altintas","year":"2011","unstructured":"Altintas DM, Vlaeminck V, Angelov D, Dimitrov S, Samarut J. Cell cycle regulated expression of NCoR might control cyclic expression of androgen responsive genes in an immortalized prostate cell line. Mol Cell Endocrinol. 2011;332:149\u201362.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-01589-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-01589-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-020-01589-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:19:23Z","timestamp":1684617563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-01589-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,2,11]]}},"alternative-id":["1589"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-01589-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The specimens of patients with PCa were conducted according to French laws and regulations. All animal experiments were performed in accordance with the animal care guidelines of the European Union and were validated by the local Animal Ethic Evaluation Committee (CECCAPP: C2EA-15 agreed by the French Ministry of High School and Research, Autorisation de projet CLB-2012-053).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}